We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$16.9B
AUM Growth
-$1.28B
Cap. Flow
-$3.58B
Cap. Flow %
-21.13%
Top 10 Hldgs %
34.65%
Holding
323
New
13
Increased
38
Reduced
39
Closed
80

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$358M
2
CRM icon
Salesforce
CRM
+$251M
3
BABA icon
Alibaba
BABA
+$173M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$159M
5
SPGI icon
S&P Global
SPGI
+$119M

Top Sells

Rank Stock Value
1
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$497M
2
TWTR
Twitter, Inc.
TWTR
+$340M
3
ZEN
ZENDESK INC
ZEN
+$296M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$294M
5
META icon
Meta Platforms (Facebook)
META
+$245M

Sector Composition

Rank Sector Weight
1 Healthcare 32.5%
2 Technology 18.76%
3 Financials 14.5%
4 Industrials 8.38%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSEM icon
51
Tower Semiconductor
TSEM
$25.2B
$69.8M 0.41%
1,615,000
+600,000
+59% +$26.1M
CVS icon
52
CVS Health
CVS
$119B
$64.7M 0.38%
694,259
-562,000
-45% -$54.2M
INSP icon
53
Inspire Medical Systems
INSP
$1.8B
$61.1M 0.36%
242,596
-239,400
-50% -$51M
SIMO icon
54
Silicon Motion
SIMO
$8.76B
$60.5M 0.36%
931,510
– –
BRKR icon
55
Bruker
BRKR
$9.07B
$58.7M 0.35%
859,300
-84,500
-9% -$5.37M
AGIO icon
56
Agios Pharmaceuticals
AGIO
$1.98B
$56.9M 0.34%
2,025,829
+529,000
+35% +$14.9M
MDGL icon
57
Madrigal Pharmaceuticals
MDGL
$11.9B
$44.4M 0.26%
+153,000
New +$15M
RVMD icon
58
Revolution Medicines
RVMD
$44.9B
$40.4M 0.24%
1,698,015
-801,985
-32% -$17.1M
PTGX icon
59
Protagonist Therapeutics
PTGX
$9.99B
$39.8M 0.24%
3,651,887
– –
LEGN icon
60
Legend Biotech
LEGN
$4.24B
$37.3M 0.22%
746,614
+508,900
+214% +$24.7M
JAZZ icon
61
Jazz Pharmaceuticals
JAZZ
$16.5B
$36.6M 0.22%
229,800
-307,700
-57% -$45.1M
PACB icon
62
Pacific Biosciences
PACB
$420M
$32.8M 0.19%
+4,004,400
New +$34.5M
ISEE
63
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$31.3M 0.18%
1,462,000
+145,000
+11% +$3.09M
ALNY icon
64
Alnylam Pharmaceuticals
ALNY
$31.6B
$30.9M 0.18%
130,056
-298,400
-70% -$63.6M
KVSC
65
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$28M 0.17%
2,809,000
– –
BACA
66
DELISTED
Berenson Acquisition Corp. I
BACA
$25.1M 0.15%
2,475,000
– –
MTAL
67
DELISTED
Metals Acquisition
MTAL
$24.9M 0.15%
2,489,700
– –
APLS
68
DELISTED
Apellis Pharmaceuticals
APLS
$23.3M 0.14%
450,400
-27,600
-6% -$1.46M
TVRD
69
Tvardi Therapeutics
TVRD
$24.8M
$22.3M 0.13%
57,617
-11,827
-17% -$4.49M
BNTX icon
70
BioNTech
BNTX
$29.3B
$21M 0.12%
+140,000
New +$21.5M
IVCP
71
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$20.1M 0.12%
1,980,000
– –
LUNR icon
72
Intuitive Machines
LUNR
$2.94B
$19M 0.11%
1,900,000
– –
SEDA
73
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$17.4M 0.1%
1,732,500
– –
BRMK
74
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$17.3M 0.1%
4,850,000
– –
VAQC
75
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$17.2M 0.1%
1,700,000
– –
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q4 2022 Portfolio in Review

As of Q4 2022, Thomas Steyer held 323 positions worth $16.9B, down 7% from $18.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Thomas Steyer withdrew a net $3.58B in Q4 2022, closing 80 positions and reducing 39 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $497M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Intuit worth $351M.

  • Thomas Steyer's largest Q4 2022 buy was Intuit: 902,100 shares worth $351M.
  • Thomas Steyer added most to Salesforce in Q4 2022, an estimated $251M increase.
  • Thomas Steyer's biggest Q4 2022 reduction was Clarivate, cutting an estimated $238M.
  • Thomas Steyer fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $497M.
  • Thomas Steyer's ten largest holdings make up 35% of its $16.9B portfolio in Q4 2022.
  • Thomas Steyer opened 13 new positions and closed 80 in Q4 2022.
  • Thomas Steyer's portfolio value fell 7% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.